Clinical Trial Update: Evaluating the Efficacy and Tolerability of ZED1227 in Subjects With Non-responsive Celiac Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the efficacy and tolerability of ZED1227 in adults with non-responsive celiac disease and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• ZED1227

Snippet

Sponsor: Dr. Falk Pharma GmbH | Conditions: Celiac Disease | Phase 2 | Status: RECRUITING